Fatal clinical course of probable invasive pulmonary aspergillosis with influenza B infection in an immunocompetent patient

Tuberculosis and Respiratory Diseases

Volumn 77, Issue 3, 2014, Pages 141-144

  Park, Dong Won ^a   Yhi, Ji Young ^a   Koo, Gunwoo ^a   Jung, Sung Jun ^a   Kwak, Hyun Jung ^a   Moon, Ji Yong ^a   Kim, Sang Heon ^a   Kim, Tae Hyung ^a   Sohn, Jang Won ^a   Shin, Dong Ho ^a   Park, Sung Soo ^a   Yoon, Ho Joo ^a  

^a Hanyang University   (South Korea)

Author keywords

Immunocompetence; Influenza B virus; Invasive pulmonary aspergillosis

Indexed keywords

C REACTIVE PROTEIN; CEFTRIAXONE; LEVOFLOXACIN; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; VORICONAZOLE;

ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE COURSE; FEVER; HUMAN; HYPOXEMIA; IMMUNOCOMPROMISED PATIENT; INFLUENZA B; LEUKOCYTOSIS; LUNG ASPERGILLOSIS; LUNG INFILTRATE; LUNG LAVAGE; MALE; MIDDLE AGED; MYALGIA; RESPIRATORY FAILURE; SORE THROAT; WHEEZING;

EID: 84908364624     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2014.77.3.141     Document Type: Article

References (14)

1. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
2. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-16.
3. Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes AR, Groeneveld AB. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med 2007;33:1694-703.
4. Stevens DA, Melikian GL. Aspergillosis in the 'nonimmunocompromised' host Immunol. Invest 2011;40:751-66.
5. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998;114:629-34.
6. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010;16:971-3.
7. Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 2012;38:1761-8.
8. Kwon OK, Lee MG, Kim HS, Park MS, Kwak KM, Park SY. Invasive pulmonary aspergillosis after influenza a infection in an immunocompetent patient. Tuberc Respir Dis 2013;75:260-3.
9. Hasejima N, Yamato K, Takezawa S, Kobayashi H, Kadoyama C. Invasive pulmonary aspergillosis associated with influenza B. Respirology 2005;10:116-9.
10. Ohnishi T, Andou K, Kusumoto S, Sugiyama H, Hosaka T, Ishida H, et al. Two cases of successfully treated invasive pulmonary aspergillosis following influenza virus infection. Nihon Kokyuki Gakkai Zasshi 2007;45:349-55.
11. Labella AM, Merel SE Influenza. Med Clin North Am 2013;97:621-45.
12. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyi-annis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.
13. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005;5:609-22.
14. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15.